GYRE - Gyre Therapeutics Inc
IEX Last Trade
13.385
-0.345 -2.578%
Share volume: 32,987
Last Updated: Fri 30 Aug 2024 07:58:15 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$13.73
-0.35
-2.51%
Summary score
36%
Profitability
16%
Dept financing
14%
Liquidity
53%
Performance
57%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-50.46%
Return on assets
-17.12%
Return on sales
-1079.24%
Return on invested capital
-33.05%
Total debt ratio
32.79%
Debt ratio change over timeo
-1.17%
Current Ratio
6.13%
Quick Ratio
6.1%
Cash Position Ratio
5.18%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-66.02%
Return on assets
-4.31%
Return on sales
27.69%
Return on invested capital
-96.14%
Total debt ratio
59.05%
Debt ratio change over timeo
-0.56%
Current Ratio
2.92%
Quick Ratio
2.8%
Cash Position Ratio
1.73%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
13.3%
Return on assets
6.62%
Return on sales
29.7%
Return on invested capital
18.92%
Total debt ratio
53.58%
Debt ratio change over time
-0.87%
Current Ratio
3.22%
Quick Ratio
2.97%
Cash Position Ratio
1.53%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
16.57%
Return on assets
-84.65%
Return on sales
-608.09%
Return on invested capital
-248.25%
Total debt ratio
-117.26%
Debt ratio change over time
-1.17%
Current Ratio
0.93%
Quick Ratio
0.86%
Cash Position Ratio
0.59%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GYRE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -50.46% | 13.79% | 34.47% | 7.43% |
| Return on assets | -17.12% | 2.76% | 3.15% | 5.62% |
| Return on sales | -1079.24% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -33.05% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 32.79% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.17% | 308.97% | -6.99% | 1.18% |
| Dept financing | 9% | 50% | 25% | 7% |
| Current Ratio | 2.92% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.8% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.73% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 8% | 19% | 43% |
| Short-term ratios | GYRE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -66.02% | 13.77% | 13.25% | 3.8% |
| Return on assets | -4.31% | 2.43% | 1.89% | 3.09% |
| Return on sales | 27.69% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -96.14% | 2.14% | 3.39% | 9.18% |
| Profitability | 23% | 71% | 68% | 82% |
| Total debt ratio | 59.05% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.56% | 46.38% | -72.08% | 1.51% |
| Dept financing | 16% | 50% | 25% | 7% |
| Current Ratio | 2.92% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.8% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.73% | 0.36% | 1.28% | 2.93% |
| Liquididy | 43% | 12% | 31% | 75% |